1. 3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazole Propanoic Acid
2. Bay U 3405
3. Bay U 3406
4. Bay U-3405
5. Bay U3405
1. 116649-85-5
2. Baynas
3. Bay U3405
4. Bay U 3405
5. Bay-u-3405
6. Bay-u 3405
7. 3-[(3r)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic Acid
8. (+)-(3r)-3-(p-fluorobenzenesulfonamido)-1,2,3,4-tetrahydrocarbazole-9-propionic Acid
9. P1ali72u6c
10. (r)-3-(3-(4-fluorophenylsulfonamido)-3,4-dihydro-1h-carbazol-9(2h)-yl)propanoic Acid
11. 9h-carbazole-9-propanoic Acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3r)-
12. En-137774
13. Chembl361812
14. Ncgc00167519-01
15. En 137774
16. Bay U 3406
17. Bay U-3405
18. (3r)-3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic Acid
19. Dsstox_cid_26685
20. Dsstox_rid_81819
21. Dsstox_gsid_46685
22. [3h]ramatroban
23. [3h]baynas
24. Baynas (tn)
25. Cas-116649-85-5
26. Ramatroban (jan/inn)
27. Ramatroban [inn:ban]
28. Unii-p1ali72u6c
29. 3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazole Propanoic Acid
30. [3h]bay U 3405
31. [3h]bay U3405
32. 3r-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic Acid
33. (3r)-3-(((4-fluorophenyl)sulfonyl)amino)-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic Acid
34. 9h-carbazole-9-propanoic Acid, 3-(((4-fluorophenyl)sulfonyl)amino)-1,2,3,4-tetrahydro-, (3r)-
35. Mfcd00887606
36. Ramatroban [mi]
37. Ramatroban [inn]
38. Ramatroban [jan]
39. Ramatroban [mart.]
40. 9h-carbazole-9-propanoic Acid, 3-(((4-fluorophenyl)sulfonyl)amino)-1,2,3,4-tetrahydro-, (r)-
41. Ramatroban [who-dd]
42. Ramatroban (bay U3405)
43. Schembl29030
44. Mls006010637
45. Gtpl1910
46. Gtpl1911
47. Dtxsid1046685
48. Chebi:32087
49. Hms3648e21
50. Bay U3405;bay-u3405
51. Ex-a4208
52. Hy-b0745
53. Zinc3798772
54. Tox21_112516
55. Ac-719
56. Bdbm50161746
57. S5286
58. Akos015966619
59. Ramatroban, >=98% (hplc), Solid
60. Tox21_112516_1
61. Ccg-268842
62. Db13036
63. Ks-1310
64. Ncgc00167519-02
65. Ncgc00167519-04
66. Ncgc00167519-07
67. Smr002530322
68. R0144
69. D01128
70. 649f855
71. A803658
72. Sr-01000883932
73. Sr-01000946208
74. J-003466
75. Sr-01000883932-1
76. Sr-01000946208-1
77. Q10357327
78. (r)-3-(3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydrocarbazol-9-yl)propanoic Acid
79. (r)-3-(3-(4-fluorophenylsulfonamido)-3,4-dihydro-1h-carbazol-9(2h)-yl)propanoicacid
80. [(4-fluorophenyl)sulfonylamino] 3-(1,2,3,4-tetrahydrocarbazol-9-yl)propanoate
81. 3(r)-[[(4-fluoro-phenyl) Sulfonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic Acid
82. 3-[(r)-3-(4-fluoro-benzenesulfonylamino)-1,2,3,4-tetrahydro-carbazol-9-yl]-propionic Acid
83. A8x
| Molecular Weight | 416.5 g/mol |
|---|---|
| Molecular Formula | C21H21FN2O4S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 416.12060649 g/mol |
| Monoisotopic Mass | 416.12060649 g/mol |
| Topological Polar Surface Area | 96.8 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 689 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Platelet Aggregation Inhibitors
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)
LOOKING FOR A SUPPLIER?
